ACLAX | VMVAX | ACLAX / VMVAX | |
Total Expense Ratio | 1.23 | 0.07 | 1,757% |
Annual Report Gross Expense Ratio | 1.23 | 0.07 | 1,757% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 6.820 | 5.198 | 131% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7B | 31B | 23% |
Annual Yield % from dividends | 1.30 | 2.22 | 59% |
Returns for 1 year | 1.31 | 7.67 | 17% |
Returns for 3 years | 0.86 | 17.51 | 5% |
Returns for 5 years | 14.85 | 65.15 | 23% |
Returns for 10 years | 11.27 | 87.87 | 13% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDT | 73.57 | 0.25 | +0.35% |
First Trust Dev Mkts Ex-US AlphaDEX® ETF | |||
LCG | 31.98 | 0.08 | +0.25% |
Sterling Capital Focus Equity ETF | |||
LIAU | 230.98 | N/A | N/A |
LifeX 2060 Infl-Prt Longevity Inc ETF | |||
NNY | 8.08 | -0.01 | -0.12% |
Nuveen New York Municipal Value Fund | |||
PRF | 43.54 | -0.12 | -0.27% |
Invesco RAFI US 1000 ETF |